Nicholas Company, Inc. Astrazeneca PLC Transaction History
Nicholas Company, Inc.
- $5.66 Billion
- Q3 2025
A detailed history of Nicholas Company, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Nicholas Company, Inc. holds 1,128,004 shares of AZN stock, worth $101 Million. This represents 1.53% of its overall portfolio holdings.
Number of Shares
1,128,004
Previous 1,139,599
1.02%
Holding current value
$101 Million
Previous $79.6 Million
8.67%
% of portfolio
1.53%
Previous 1.39%
Shares
16 transactions
Others Institutions Holding AZN
# of Institutions
1,541Shares Held
503MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...